Vivos (RDGL) EBIT (2010 - 2025)
Vivos (RDGL) reported EBIT of -$1.1 million for Q4 2025, down 65.57% on a YoY basis from -$3.2 million in Q4 2024, and down 106.34% sequentially from -$531023.0 in Q3 2025.
Vivos (RDGL) EBIT (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of EBIT data on file, last reported at -$1.1 million in Q4 2025.
- For the quarter ending Q4 2025, EBIT fell 65.57% year-over-year to -$1.1 million; the trailing twelve-month figure through Dec 2025 stood at -$3.2 million (down 21.53% YoY), and the FY2025 full-year result was -$3.2 million, down 21.53% from the prior year.
- EBIT fell to -$1.1 million in Q4 2025, from -$531023.0 in the prior quarter.
- In the past five years, EBIT ranged from a high of -$194583.0 in Q3 2021 to a low of -$1.9 million in Q2 2021.
- A 5-year average of -$679106.2 and a median of -$681202.5 in 2023 frame the typical range for EBIT.
- Across the five-year window, EBIT sank 1343.08% in 2021 and surged 66.78% in 2023, its largest moves.
- Tracing RDGL's EBIT over 5 years: stood at -$218440.0 in 2021, then sank by 223.04% to -$705653.0 in 2022, then plunged by 33.61% to -$942791.0 in 2023, then grew by 29.8% to -$661800.0 in 2024, then plunged by 65.57% to -$1.1 million in 2025.
- Business Quant data shows RDGL's EBIT at -$1.1 million in Q4 2025, -$531023.0 in Q3 2025, and -$674772.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | -1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | -531,023.00 |
| Jun 30, 2025 | -674,772.00 |
| Mar 31, 2025 | -863,532.00 |
| Dec 31, 2024 | -661,800.00 |
| Sep 30, 2024 | -843,145.00 |
| Jun 30, 2024 | -522,309.00 |
| Mar 31, 2024 | -577,129.00 |
| Dec 31, 2023 | -942,791.00 |
| Sep 30, 2023 | -687,633.00 |
| Jun 30, 2023 | -914,405.00 |
| Mar 31, 2023 | -248,318.00 |
| Dec 31, 2022 | -705,653.00 |
| Sep 30, 2022 | -277,065.00 |
| Jun 30, 2022 | -787,538.00 |
| Mar 31, 2022 | -747,493.00 |
| Dec 31, 2021 | -218,440.00 |
| Sep 30, 2021 | -194,583.00 |
| Jun 30, 2021 | -1.85 Mn |
| Mar 31, 2021 | -235,090.00 |